Failure mode and bimodal restenosis of drug-coated balloon in femoropopliteal intervention

被引:7
|
作者
Huang, Hsuan-Li [1 ,2 ]
Chou, Hsin-Hua [1 ,2 ]
Chen, I-Chih [3 ]
Hsieh, Chien-An [1 ]
Jang, Shih-Jung [1 ]
Tzeng, I-Shiang [4 ]
Ko, Yu-Lin [1 ,2 ]
机构
[1] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Div Cardiol, Dept Internal Med, New Taipei, Taiwan
[2] Tzu Chi Univ, Sch Med, Hualien, Taiwan
[3] Tainan Municipal Hosp, Div Cardiol, Dept Internal Med, Tainan, Taiwan
[4] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Res, New Taipei, Taiwan
关键词
Drug-coated balloon; Restenosis; Femoropopliteal; Failure mode; PACLITAXEL-ELUTING STENTS; CLINICAL-OUTCOMES; ARTERY-DISEASE; ZILVER PTX; FEMORAL-ARTERY; CLASSIFICATION; EPIDEMIOLOGY; PREVALENCE; PATTERNS; IMPACT;
D O I
10.1016/j.ijcard.2018.02.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pattern of DCB restenosis and associated outcomes in facing complex femoropopliteal lesions remain uncertain. Methods: Data were retrospectively collected from dual centers in Taiwan on patients who underwent treatment with DCBs for femoropopliteal lesions between 2013 and 2016. The restenosis pattern was categorized by the index-treated length. Clinical outcomes and time to DCB restenosis were retrospectively analyzed. Cox proportional hazards model identified restenosis predictors. Results: We recruited a total of 164 patients (91 men; median age 73 years) into the final analysis. The mean lesion length was 204.0 +/- 109.2 mm. Of them, 45% total occlusions, 28% severe calcification and 15% in-stent restenosis were treated. Fifty-five patients have DCB restenosis (28 focal and 27 diffuse-occlusive patterns) over a 55-month follow-up. The median restenosis time emerged as a bimodal pattern with a significant difference between the diffuse-occlusive and focal restenosis group (225 vs. 484 days, P = 0.01). The 1-year patency rate after reintervention for DCB restenosis also was different between both restenosis group (29% vs. 65%, P = 0.017). The anticipated timing of escape for diffuse-occlusive or focal restenosis was 687 and 1068 days, respectively. Independent factorswere lesion length (P = 0.049) for diffuse-occlusive restenosis and lumen gain of the popliteal artery for focal restenosis (P = 0.034). Conclusions: This study demonstrated time to DCB failure emerged as a bimodal pattern of distribution and associations of restenosis pattern to subsequent outcomes after the repeated intervention. Exemption from late catchup restenosis required 3-year observation instead of the 1-year mark for conventional treatment. (c) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:170 / 177
页数:8
相关论文
共 50 条
  • [31] Association of Postangioplasty Femoropopliteal Dissections With Outcomes After Drug-Coated Balloon Angioplasty in the Femoropopliteal Arteries
    Giannopoulos, Stefanos
    Strobel, Aaron
    Rudofker, Eric
    Kovach, Christopher
    Schneider, Peter A.
    Armstrong, Ehrin J.
    JOURNAL OF ENDOVASCULAR THERAPY, 2021, 28 (04) : 593 - 603
  • [32] Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
    Wang, Hui
    Wu, Sensen
    Meng, Wenzhuo
    Pan, Dikang
    Ning, Yachan
    Guo, Jianming
    Guo, Lianrui
    Gu, Yongquan
    JOURNAL OF CARDIOTHORACIC SURGERY, 2024, 19 (01)
  • [33] Systematic Review and Meta-Analysis of Drug-Coated Balloon Angioplasty for In-Stent Restenosis in Femoropopliteal Artery Disease
    Zhen, Yanhua
    Ren, Haiyan
    Chen, Jie
    Chang, Zhihui
    Wang, Chuanzhuo
    Zheng, Jiahe
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 33 (04) : 368 - +
  • [34] Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis
    Tong, Zhu
    Guo, Lianrui
    Qi, Lixing
    Cui, Shijun
    Gao, Xixiang
    Li, Yang
    Guo, Jianming
    Gu, Yongquan
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [35] Drug-Coated Balloon in Primary Percutaneous Coronary Intervention
    Zhao, Hui
    Miao, Runran
    Lin, Fei
    Zhao, Guoan
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2023, 2023
  • [36] Drug-coated balloon in superficial femoral artery in-stent restenosis
    Gerardi, Donato
    Alfani, Arturo
    Tesorio, Tullio
    Cioppa, Angelo
    Esposito, Giovanni
    Stabile, Eugenio
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2018, 14 (01): : 9 - 14
  • [37] Differential Effects of Drug-Coated Balloon Angioplasty for In-Stent Restenosis
    Hong, Myeong-Ki
    Lee, Seung-Yul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (21) : 2679 - 2681
  • [38] Cutting Balloon Combined with Drug-Coated Balloon Angioplasty for the Treatment of In-Stent Restenosis
    Zheng, You-Cheng
    Lee, Wei-Chieh
    Fang, Hsiu-Yu
    Chen, Chien-Jen
    Yang, Cheng-Hsu
    Wu, Chiung-Jen
    Fang, Chih-Yuan
    INTERNATIONAL HEART JOURNAL, 2021, 62 (06) : 1213 - 1220
  • [39] Atherectomy plus drug-coated balloon versus drug-coated balloon only for treatment of femoropopliteal artery lesions: A systematic review and meta-analysis
    Lin, Feng
    Wang, Haoran
    Ding, Wenjie
    Chen, Gan
    Zhang, Zhigong
    VASCULAR, 2021, 29 (06) : 883 - 896
  • [40] Drug-Coated Balloon for Long Femoropopliteal Lesions: Creating a Data Network Effect
    Banerjee, Subhash
    Khalili, Houman
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (10)